Cargando…
A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab
Objective: Although emicizumab is a bispecific, monoclonal antibody that has led to a significant improvement of treatment for hemophilia A patients with inhibitors, the routine monitoring of patients treated with emicizumab is difficult. Thrombin time (TT) reflects thrombin burst, which mainly depe...
Autores principales: | Wada, Hideo, Shiraki, Katsuya, Matsumoto, Takeshi, Suzuki, Kei, Yamashita, Yoshiki, Tawara, Isao, Shimpo, Hideto, Shimaoka, Motomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605059/ https://www.ncbi.nlm.nih.gov/pubmed/36294464 http://dx.doi.org/10.3390/jcm11206142 |
Ejemplares similares
-
The Reevaluation of Thrombin Time Using a Clot Waveform Analysis
por: Wada, Hideo, et al.
Publicado: (2021) -
The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate
por: Matsumoto, Takeshi, et al.
Publicado: (2023) -
Clot Waveform Analysis for Hemostatic Abnormalities
por: Wada, Hideo, et al.
Publicado: (2023) -
Clot Waveform Analysis Demonstrates Low Blood Coagulation Ability in Patients with Idiopathic Thrombocytopenic Purpura
por: Wada, Hideo, et al.
Publicado: (2021) -
Update on the Clot Waveform Analysis
por: Wada, Hideo, et al.
Publicado: (2020)